Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Data presented on first cloned, double knock-out miniature swine

15.01.2003


Important goal achieved in potential animal-to-human organ transplantation



In a session today at the annual meeting of the International Embryo Transfer Society (IETS), Randall Prather, Ph.D., Distinguished Professor of Reproductive Biotechnology at the University of Missouri-Columbia, announced the successful cloning of the first miniature swine with both copies of a specific gene "knocked out" of its DNA. The ultimate goal of this research, which is being conducted in partnership with Immerge BioTherapeutics, Inc (a BioTransplant Incorporated (Nasdaq:BTRN)/Novartis Pharma AG (NYSE:NYS) joint venture company), is to develop a herd of miniature swine that can be used as a safe source for human transplantation, a process known as xenotransplantation.

"The fact that we have been able to clone this particular strain of miniature swine with both copies of the gene that produces GGTA1 knocked out is a very exciting step for the field of xenotransplantation," said Dr. Prather, a researcher in MU’s College of Agriculture, Food and Natural Resources. "Organs from regular swine are too large for human transplant, and this particular strain of miniature swine has been refined for years solely for its potential use in humans."


New options for organ sources are desperately needed to treat the rapidly increasing number of critically ill people on the transplant waiting list (more than 80,000 in the U.S. alone). Researchers have targeted the pig as the best potential candidate for an alternative organ source because of the similarity between human and pig organs and the relative ease of breeding. However, the massive rejection response mounted by the human immune system has been a major hurdle in this research.

A key player in this rejection process is the gene called a-1,3-galactosyltransferase or GGTA1 that produces a sugar molecule. When a foreign organ is introduced, human antibodies attach to the sugar molecule on the surface of pig cells produced from the action of the GGTA1 molecule, thus killing the organ. With both copies of this gene eliminated, the antibodies cannot attach, halting the early rejection process.

Dr. Robert Hawley and scientists at Immerge, in collaboration with Dr. Kenth Gustafsson, first identified the gene that produces GGTA1 and eliminated, or knocked it out, of the DNA of the cells from the miniature swine. This genetic material was then sent to Dr. Prather’s lab, where Dr. Liangxue Lai and colleagues implanted it into an egg that had its DNA eliminated. The egg was stimulated to begin dividing and was later implanted into a sow. Prather and Immerge announced in January 2002 in the journal Science that they had successfully cloned the world’s first single knock-out miniature swine. The genetic material from these swine was then re-engineered with the aim of knocking out the second copy of this critical gene. These cells were then subjected to another round of nuclear transfer cloning, leading to the birth of the double knock-out piglet on November 18, 2002.

In addition to the modified genetics, the Immerge miniature swine also have other important advantages as potential transplantation candidates.

"The strain of swine we are working with seems to be incapable of transmitting Porcine Endogenous Retrovirus (PERV) to human cells in culture, as we reported in March 2002 in the Journal of Virology," said Julia Greenstein, Ph.D., CEO and President, of Immerge. Unlike other viruses, which can be eliminated either through breeding or raising pigs in a clean lab environment, multiple copies of PERV form part of the normal genomic DNA of pigs and are therefore passed from one generation to the next "Although the risk of any harm posed by PERV to xenotransplant recipients may be purely theoretical, use of this line of miniature swine would help minimize this particular risk of this new technology," said Dr. Greenstein.


The University of Missouri-Columbia has a long-standing research collaboration with Immerge and BioTransplant Incorporated in the field of porcine genetic engineering. This close collaboration has allowed this important research to progress at an accelerated pace. The current collaboration is supported by a National Institutes of Health Small Business Innovative Research grant.

Immerge BioTherapeutics was formed on September 26, 2000, as a joint venture between Novartis Pharma AG and BioTransplant Incorporated. The company, which began operations on January 2, 2001, focuses its research efforts toward developing therapeutic applications for xenotransplantation. The name of the company derives from its use of immunology to address the challenges of conducting transplants between species.

Susan Hayes | EurekAlert!

More articles from Life Sciences:

nachricht Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University

nachricht How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>